Accenture Acquires Alfahealth for €900M; Morgan Stanley Downgrades to Equal-Weight
ACN is trading near its 52-week low of $155.815 (1.5% above the low).
Summary
Accenture announced the acquisition of digital health company Alfahealth for €900 million, a material strategic investment. This follows earlier news of the acquisition but provides the specific price for the first time. Separately, Morgan Stanley downgraded Accenture to Equal-Weight, citing concerns over heavy AI spending and a lack of clear budget growth in IT services. The company is also slated to report Q3 earnings next week, with a consensus EPS of $3.71. Q3 results next week will be key to understanding the impact of these strategic moves and market conditions.
At the time of this announcement, ACN was trading at $158.21 on NYSE in the Technology sector, with a market capitalization of approximately $95.8B. The 52-week trading range was $155.82 to $315.95. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.